Skip to content

Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB

Utility of Quantitative Imaging Parameters from Deep Learning-based CT Segmentation in Assessing Hepatic Steatosis and Fibrosis in Chronic Hepatitis B: a Prospective Study Using MRI As the Reference Standard

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06616103
Enrollment
111
Registered
2024-09-27
Start date
2024-09-26
Completion date
2025-08-31
Last updated
2024-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B, Steatosis of Liver, Fibrosis and Cirrhosis of Liver

Brief summary

This study aims to evaluate diagnostic performance of CT attenuation parameters acquired using deep learning algorithm in assessing hepatic steatosis and fibrosis.

Interventions

noncontrast abdominal CT

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic hepatitis B * no chronic liver disease other than chronic hepatitis B * Body mass index >= 23

Exclusion criteria

* pregnant women * unable to perform MRI examinations due to claustrophobia or metallic foreign body * suspicious hepatic malignancy on previous imaging studies * history of local treatment for hepatic lesions * history of surgery or catheter insertion of liver or spleen

Design outcomes

Primary

MeasureTime frameDescription
diagnostic performance of CT attenuatio parameters in assessing hepatic steatosis and fibrosisAt the time of enrollmentdiagnostic performance of CT attenuatio parameters in assessing hepatic steatosis and fibrosis using MRI-PDFF and MR elastography as reference standards

Secondary

MeasureTime frameDescription
Consistency between MRI-derived body composition data and CT-derived dataAt the time of enrollmentConsistency between MRI-derived body composition data and CT-derived data using automated 3D organ segmentation algorithm

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026